Intratemporal facial nerve XXXX : clinical presentation and management.

@entity808 @entity1 @entity5 @entity2103 @entity3541 @entity393
UNASSIGNED: Facial nerve @entity808 is the most common @entity5 , but its therapeutic strategy remains debated. The aim of this study is to analyze the @entity2103 and the hearing outcomes after surgery or wait-and-scan policy in a facial nerve @entity808 series. A monocentric retrospective review of medical charts of @entity1 followed for an intratemporal facial nerve @entity808 between 1988 and 2013 was performed. Twenty-two @entity1 were included. Data were extracted pertaining to the following variables: @entity1 demographics, @entity5 localization, clinical and imaging features, @entity2103 and hearing levels, and details of surgical intervention. The majority of @entity5 were located at the geniculate ganglion. Initial symptoms were mainly @entity3541 and @entity393 . The average follow-up was 4.8      4.5  years. Nineteen @entity1 underwent surgery, and three @entity1 were observed. After surgery, 11 @entity1 had a stable or improved  @entity2103 (57.9  %), and 8 @entity1 had a worsened  @entity2103 (42.1  %). @entity2103 was in the majority of cases a HB grade III, depending on surgical strategy. No @entity1 presented a postoperative HB grade V or VI. Regarding the hearing, it remained stable after surgery in 52.6  % of cases, and improved in 10.5  % of cases. Among monitored @entity1 , @entity2103 and hearing remained stable. Surgery for facial nerve @entity808 is a safe and effective option in the treatment of these @entity5 .
